LogicBio Therapeutics (LOGC) Misses Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
STZ, NKE, PRGS, More
EPS Growth %: +82.6%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
STZ, NKE, PRGS, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.50).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA is bearish on Indecies, sees shift to value stocks
- MediaTek Inc. (2454:TT) (MDTKF) PT Raised to NT$5,800 at Nomura/Instinet
- BofA Securities Downgrades Logitech International (LOGI) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
